Profil bibliographique

José Fuentes Pradera

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

42Publications signalées

946Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Lung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and TreatmentPARP inhibition in cancer therapyCancer Immunotherapy and Biomarkers

Publications récentes

2026 articleOpenAlex

First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non–Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study

Jhanelle E. Gray, Joel W. Neal, Jyoti D. Patel, Stephen V. Liu et autres

2 citationsClinical Cancer Research

Accès ouvert 2025 articleOpenAlex

First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study

Martin Reck, Jyoti D. Patel, Jhanelle E. Gray, Noemı́ Reguart et autres

9 citationsJournal of Thoracic Oncology

Accès ouvert 2025 articleOpenAlex

Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 study

Rebecca Kristeleit, S. Ghamande, Alla Lisyanskaya, A. Oaknin et autres

6 citationsAnnals of Oncology

2025 conference-abstractOpenAlex

PP01.03 Characterization of Mutated KRAS Genotype and Clinical Outcomes in Patients With Advanced NSCLC Treated With Mecbotamab Vedotin, a CAB-AXL-ADC

Julia Rotow, Grace K. Dy, Edwin Yau, Elaine Shum et autres

0 citationsJournal of Thoracic Oncology

Accès ouvert 2024 articleOpenAlex

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Myung‐Ju Ahn, Kentaro Tanaka, Luis Paz‐Ares, Robin Cornelissen et autres

222 citationsJournal of Clinical Oncology

Accès ouvert 2024 articleOpenAlex

757P Sustained long-term responders to niraparib maintenance in recurrent platinum-sensitive high-grade ovarian cancer (PSROC): A subanalysis of the GEICO-88R study

Juan Bañuelos, Isabel Palacio Vázquez, C. Maximiano Alonso, P. Estevez Garcia et autres

0 citationsAnnals of Oncology

Accès ouvert 2024 conference-abstractOpenAlex

PPD01.06 Sacituzumab Govitecan + Pembrolizumab in 1L Metastatic Non–Small Cell Lung Cancer: Preliminary Results of the EVOKE-2 Study

Jyoti D. Patel, Byoung Chul Cho, Manuel Cobo, Roxanna Reyes Cabanillas et autres

0 citationsJournal of Thoracic Oncology

2024 conference-abstractOpenAlex

Final safety results from ATHENA–MONO (GOG-3020/ENGOT-ov45), a randomized, placebo-controlled, double-blind, phase 3 trial evaluating rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer.

David M. O’Malley, Bradley Monk, Myong Cheol Lim, José Fuentes Pradera et autres

5 citationsJournal of Clinical Oncology

Accès ouvert 2024 articleOpenAlex

55P Long-term responders (LTR) with niraparib maintenance in platinum-sensitive recurrent high-grade serous ovarian cancer (PSROC) focusing on subsequent therapies and post-progression outcomes (GEICO-88R study)

Juan Bañuelos, Yolanda García García, Alfonso Yubero, A. Gallego Martínez et autres

0 citationsESMO Open

2024 conference-abstractOpenAlex

Sacituzumab govitecan (SG) + pembrolizumab (pembro) in first-line (1L) metastatic non-small cell lung cancer (mNSCLC) with PD-L1 ≥ 50%: Cohort A of EVOKE-02.

Jyoti D. Patel, Byoung Chul Cho, Manuel Cobo, Roxana Reyes Cabanillas et autres

20 citationsJournal of Clinical Oncology

Accès ouvert 2024 conference-abstractOpenAlex

Analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with carboplatin-paclitaxel after multiple lines of treatment.

Elisa María Fernández Pérez, Isabel Beltrán Guerra, A. Sanchez Vegas, Carlos E. Robles et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2023 articleOpenAlex

Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B

Xiuning Le, Luis Paz‐Ares, Jan P. van Meerbeeck, Santiago Viteri et autres

18 citationsCell Reports Medicine

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.